INmune Bio, Inc.
INMB
$7.32
$0.010.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.64% | -19.76% | -35.04% | -49.02% | -31.26% |
| Total Receivables | -42.30% | -37.25% | 66.81% | 21.72% | -71.14% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -79.96% | -42.74% | -62.99% | -69.14% | -59.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -43.26% | -21.40% | -32.53% | -47.57% | -38.24% |
|
|
|||||
| Total Current Assets | -43.26% | -21.40% | -32.53% | -47.57% | -38.24% |
| Net Property, Plant & Equipment | -25.85% | -24.55% | -22.44% | -19.79% | -18.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -39.69% | -36.43% | -37.69% | 7.07% | 32.32% |
| Total Assets | -30.59% | -15.82% | -24.77% | -36.69% | -30.31% |
|
|
|||||
| Total Accounts Payable | -17.24% | 188.16% | 289.18% | 347.47% | 51.77% |
| Total Accrued Expenses | -28.57% | -30.38% | 1,444.44% | 522.22% | 288.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -98.61% | -73.99% | -49.42% | -0.34% | 97.37% |
| Total Finance Division Other Current Liabilities | 5.73% | 10.69% | -6.96% | -12.01% | -20.62% |
| Total Other Current Liabilities | 5.73% | 10.69% | -6.96% | -12.01% | -20.62% |
| Total Current Liabilities | -60.89% | -3.71% | 15.29% | 69.70% | 69.12% |
|
|
|||||
| Total Current Liabilities | -60.89% | -3.71% | 15.29% | 69.70% | 69.12% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -38.54% | -33.95% | -30.45% | -27.71% | -24.52% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -60.42% | -21.48% | -19.37% | -4.67% | -13.04% |
|
|
|||||
| Common Stock & APIC | 23.01% | 23.09% | 15.04% | 4.81% | 4.84% |
| Retained Earnings | -34.77% | -36.65% | -36.27% | -35.36% | -32.97% |
| Treasury Stock & Other | 28.04% | -40.95% | -0.14% | 5.51% | -14.31% |
| Total Common Equity | -14.04% | -11.97% | -28.37% | -48.96% | -37.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.04% | -11.97% | -28.37% | -48.96% | -37.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.84% | -13.54% | -26.80% | -47.51% | -36.54% |
|
|
|||||